Business Wire

Jämtkraft Selects Hansen for Trading Operations

Share

Hansen Technologies (ASX:HSN) is pleased to announce a new agreement with Jämtkraft, a leading Swedish utility. As part of the agreement, Jämtkraft has selected Hansen Trade to cover day-ahead trading operations, and for monitoring short-term positions. Jämtkraft now joins Hansen’s family of over 600 global customers.

Hansen Trade Day-Ahead Trading streamlines Jämtkraft’s daily bidding process, maintains order structures and handles day-ahead trade results automatically. The Day-Ahead Trading solution enables order configurations to be tagged to specific assets; this means that it can disaggregate trade results from the portfolio level, right down to the individual asset, if needed. As a SaaS service, Hansen Trade Day-Ahead Trading is compliant with market changes and is connected to Nord Pool’s new auction platform, which goes live in the Nordics in early 2022.

Hansen Trade Position Visualisation enables Jämtkraft to monitor and analyse short-term positions in real-time. An example would be the root cause of imbalance volumes. The operator can view the total imbalance position on a price-area level, including colour-masking for exceptionally high or low values. The Position Visualisation solution then enables the operator to drill deeper to portfolio (such as production type), sub-portfolio (hydropower assets in the same river) and finally to the asset level, to examine the cause for exceptional values on the top level.

Andreas Wiklander, Head of Operations, Jämtkraft, commented: “With Hansen Trade, we can modernise our daily trading operations, and get better and easier visibility into our trading positions. At Jämtkraft, we were impressed with the demonstration of Hansen Trade’s features and coupled with the positive reception that the solution has received from several energy companies in the region – being a vital enabler of day-to-day trading operations – we are more than confident that Hansen Trade is the answer when it comes to addressing our challenge.”

Scott Weir, Regional President, EMEA, Hansen Technologies, commented: “We continue to see a major uptick in the deployment of Hansen Trade across the Nordic region. This new agreement with Jämtkraft, in addition to the strong endorsement from our other customers in the region, attests to the strength of Hansen and our solutions in addressing the complexities of the digital era.”

Jämtkraft’s selection of Hansen Trade follows other recent agreements with Fortum, Power-Deriva and Tampereen Sähkölaitos. Run as a modular, cloud-based SaaS solution, Hansen Trade fully meets the flexibility and scalability demands of the evolving energy trading market.

For further information about Hansen Technologies, please visit www.hansencx.com.

About Hansen Technologies

Hansen Technologies (ASX: HSN) is a leading global provider of software and services to the energy, water and communications industries. With its award-winning software portfolio, Hansen serves 600+ customers in over 80 countries, helping them to create, sell and deliver new products and services, manage and analyse customer data, and control critical revenue management and customer support processes.

For more information, visit www.hansencx.com

About Jämtkraft

Jämtkraft AB is a utilities company based in Jämtland, Sweden. The company is owned by the municipalities of Åre, Krokom and Östersund. Jämtkraft AB engages in producing, distributing and selling electric power to residential and business customers throughout Sweden. Renewable district heating is also part of the business portfolio. Jämtkraft AB has a long tradition of focusing on sustainability and climate-smart living, as well as sustainable and long-term business.

For more information, visit https://www.jamtkraft.se/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Adnan Bashir
Senior Manager, Global Corporate Communications
Hansen Technologies
+1 647-204-0999

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 13:30:00 CEST | Press release

IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde

HiddenA line styled icon from Orion Icon Library.Eye